These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2258577)

  • 1. HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.
    van der Gaag R; Wiersinga WM; Koornneef L; Mourits MP; Prummel MF; Berghout A; de Vries RR; Schreuder GM; D'Amaro J
    J Endocrinol Invest; 1990 Jun; 13(6):489-92. PubMed ID: 2258577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
    Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
    Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR associations with Graves' disease in eastern Hungary.
    Stenszky V; Kozma L; Balazs C; Farid NR
    Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin versus corticosteroid in treatment of Graves' ophthalmopathy.
    Baschieri L; Antonelli A; Nardi S; Alberti B; Lepri A; Canapicchi R; Fallahi P
    Thyroid; 1997 Aug; 7(4):579-85. PubMed ID: 9292946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
    Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclosporine and Graves' ophthalmopathy.
    Gayno JP; Strauch G
    Horm Res; 1987; 26(1-4):190-7. PubMed ID: 3596468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
    Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
    J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA and autoimmune endocrine disease 1985.
    Farid NR; Thompson C
    Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
    Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic factors in Graves' ophthalmopathy.
    Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
    Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
    J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of immune damage in Graves' ophthalmopathy.
    Hiromatsu Y; Wang PW; Wosu L; How J; Wall JR
    Horm Res; 1987; 26(1-4):198-207. PubMed ID: 3596469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers.
    Kendall-Taylor P; Stephenson A; Stratton A; Papiha SS; Perros P; Roberts DF
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):601-10. PubMed ID: 3254259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenetics of Graves' ophthalmopathy.
    Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
    Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy].
    Yang H; Wu Z; Huang X; Xie C; Yang P
    Yan Ke Xue Bao; 1999 Jun; 15(2):78-80. PubMed ID: 12579704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients.
    Ohtsuka K; Nakamura Y
    Am J Ophthalmol; 1998 Dec; 126(6):805-10. PubMed ID: 9860004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
    Bednarek J; Wysocki H; Sowiński J
    Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex (MHC) factors predisposing to and protecting against Graves' eye disease.
    Frecker M; Mercer G; Skanes VM; Farid NR
    Autoimmunity; 1988; 1(4):307-15. PubMed ID: 2979624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.